What is the treatment for infectious mononucleosis (mono)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Infectious Mononucleosis (Mono)

The treatment for infectious mononucleosis is primarily supportive care, as it is a self-limited viral illness with no specific antiviral therapy recommended for routine treatment. 1, 2

Diagnosis

Before initiating treatment, confirm the diagnosis with:

  • Clinical presentation: Triad of fever, tonsillar pharyngitis, and lymphadenopathy (particularly posterior cervical) in patients 10-30 years of age 1, 2
  • Laboratory findings: Atypical lymphocytosis (>10% of total lymphocyte count) and positive heterophile antibody test (Monospot) 2, 3
  • If Monospot is negative but clinical suspicion remains high, consider EBV-specific serologic testing for viral capsid antigens 4

Supportive Care

  1. Hydration and Rest

    • Ensure adequate hydration 1
    • Allow activity as tolerated based on the patient's energy level (do not enforce strict bed rest) 1, 2
    • Fatigue may persist for several months after acute infection 2
  2. Symptom Management

    • Analgesics and antipyretics for pain and fever control 1
    • Throat lozenges or warm salt water gargles for pharyngitis symptoms 2

Activity Restrictions

  • Avoid contact or collision sports for at least 4-8 weeks after symptom onset or while splenomegaly is present 1, 3
  • This restriction is critical due to the risk of splenic rupture, which occurs in 0.1-0.5% of cases and is potentially life-threatening 2, 4

Medications NOT Routinely Recommended

  • Corticosteroids are not recommended for routine treatment 1
    • Exception: May be considered for patients with severe pharyngeal edema or respiratory compromise 1
  • Acyclovir or other antivirals are not recommended for routine treatment 1
  • Antihistamines are not recommended for routine treatment 1

Monitoring and Follow-up

  • Monitor for resolution of symptoms, which typically occurs within 2-4 weeks 2
  • Be aware that fatigue may persist for several months 1, 2
  • Consider follow-up physical examination to assess for resolution of splenomegaly before clearing for return to contact sports 3

Complications to Watch For

  • Splenic rupture (most feared complication) 2, 4
  • Respiratory compromise from severe pharyngeal edema 1
  • Hepatitis (occurs in approximately 10% of cases) 5
  • Neurologic complications (rare) 4
  • Hematologic complications (rare) 4
  • Chronic fatigue syndrome (infectious mononucleosis is a risk factor) 2

Special Considerations

  • Adolescents and young adults (15-24 years) are most commonly affected 2
  • EBV is transmitted primarily through saliva ("kissing disease") 3, 5
  • Most patients have an uneventful recovery with supportive care alone 2

Remember that infectious mononucleosis is generally a benign, self-limited disease that requires supportive care rather than specific antiviral therapy 2, 4.

References

Research

Epstein-Barr virus infectious mononucleosis.

American family physician, 2004

Research

Infectious Mononucleosis: An Updated Review.

Current pediatric reviews, 2024

Research

American Medical Society of Sports Medicine Position Statement: Mononucleosis and Athletic Participation.

Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine, 2023

Research

Diagnosis and treatment of infectious mononucleosis.

American family physician, 1994

Research

[Infectious mononucleosis--a "childhood disease" of great medical concern].

Medizinische Monatsschrift fur Pharmazeuten, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.